Amphastar Pharmaceuticals to Present at the Bank of America Merrill Lynch 2015 Health Care Conference

Go back to Amphastar Pharmaceuticals to Present at the Bank of America Merrill Lynch 2015 Health Care Conference

Amphastar Pharma (AMPH) Reports Q1 Loss of 1c/Share

May 13, 2015 6:01 AM EDT

Amphastar Pharma (NASDAQ: AMPH) reported Q1 EPS of ($0.01), versus $0.00 reported last year. Revenue for the quarter came in at $56.89 million, versus $45.87 million reported last year.

For earnings history and earnings-related data on Amphastar Pharma (AMPH) click here.

... More